Top Markets
#1 Black Phoenix Black Phoenix +742.50%
#2 Beam Beam +45.75%
#3 THORChain THORChain +19.76%
#4 SAFEcoin SAFEcoin +17.86%
#5 TENDIES TENDIES +17.26%
#6 Bless Bless +16.36%
#7 MiL.k Alliance MiL.k Alliance +16.34%
#8 Wrapped STX (Velar) Wrapped STX (Velar) +15.76%
#9 THORChain Yield THORChain Yield +14.89%
#10 EfficientFrontier EfficientFrontier +14.52%
Coin of the day
Black Phoenix Black Phoenix
Settings
Language
ENGLISH
Currency
USD
Theme
Pharvaris N.V. Pharvaris N.V.

Pharvaris N.V.

PHVS
Rank in Stocks #5577
Pharvaris N.V., a late-stage biopharmaceutical company, focuses on the... Pharvaris N.V., a late-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs covering angioedema and other bradykinin-mediated diseases. The company develops deucrictibant, a small molecule bradykinin B2-receptor antagonist to treat attacks due to bradykinin-mediated angioedema, including hereditary angioedema (HAE) and acquired angioedema due to C1-inhibitor deficiency (AAE-C1INH), which is in phase 3, as well as in phase 3 trials for treatment and prophylaxis of HAE attacks; and extended-release tablet and immediate-release capsule formulation of deucrictibant. Pharvaris N.V. was incorporated in 2015 and is headquartered in Zug, Switzerland.
Share Price
$36.98
Last synced: 2026-08-26
Market Cap
$2.58B
Change (1 day)
-0.67%
Change (1 year)
55.51%
Country
NL
Trade Pharvaris N.V. (PHVS)

Category

Healthcare
P/B ratio for Pharvaris N.V. (PHVS)
P/B ratio as of 2026 TTM: 0
According to Pharvaris N.V. latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for Pharvaris N.V. from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 3.7087 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH